53
Participants
Start Date
October 31, 2004
Primary Completion Date
December 31, 2011
Study Completion Date
June 30, 2012
GM-CSF
2,000 mcg injected into the liver every 4 weeks alternating between right or left lobe when tumors present throughout liver.
Embolization
A catheter will be introduced to one of the hepatic arteries by way of the femoral artery (groin) to allow injection of GM-CSF in combination with ethiodized oil and gelatin sponge providing a temporary blockage of the blood supply from the hepatic (liver) artery
Thomas Jefferson University, Philadelphia
National Cancer Institute (NCI)
NIH
Sidney Kimmel Cancer Center at Thomas Jefferson University
OTHER